Our top pick for
Qumu Corporation is a software-application business based in the US. Qumu Corporation shares (QUMU) are listed on the NASDAQ and all prices are listed in US Dollars. Qumu Corporation employs 151 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$2.32|
|52-week range||$2.07 - $10.50|
|50-day moving average||$2.44|
|200-day moving average||$3.56|
|Wall St. target price||$6.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.04|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-21)||7.41%|
|1 month (2021-09-28)||-9.38%|
|3 months (2021-07-28)||-9.38%|
|6 months (2021-04-28)||-61.33%|
|1 year (2020-10-28)||-48.33%|
|2 years (2019-10-28)||-22.92%|
|3 years (2018-10-26)||2.42|
|5 years (2016-10-28)||3.28|
|Revenue TTM||$25.2 million|
|Gross profit TTM||$20.7 million|
|Return on assets TTM||-22.76%|
|Return on equity TTM||-112.54%|
|Market capitalisation||$39 million|
TTM: trailing 12 months
There are currently 146,859 Qumu Corporation shares held short by investors – that's known as Qumu Corporation's "short interest". This figure is 13% up from 129,993 last month.
There are a few different ways that this level of interest in shorting Qumu Corporation shares can be evaluated.
Qumu Corporation's "short interest ratio" (SIR) is the quantity of Qumu Corporation shares currently shorted divided by the average quantity of Qumu Corporation shares traded daily (recently around 212839.13043478). Qumu Corporation's SIR currently stands at 0.69. In other words for every 100,000 Qumu Corporation shares traded daily on the market, roughly 690 shares are currently held short.
However Qumu Corporation's short interest can also be evaluated against the total number of Qumu Corporation shares, or, against the total number of tradable Qumu Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Qumu Corporation's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Qumu Corporation shares in existence, roughly 10 shares are currently held short) or 0.0098% of the tradable shares (for every 100,000 tradable Qumu Corporation shares, roughly 10 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Qumu Corporation.
Find out more about how you can short Qumu Corporation stock.
We're not expecting Qumu Corporation to pay a dividend over the next 12 months.
Qumu Corporation's shares were split on a 3:2 basis on 9 April 2000. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Qumu Corporation shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Qumu Corporation shares which in turn could have impacted Qumu Corporation's share price.
Over the last 12 months, Qumu Corporation's shares have ranged in value from as little as $2.07 up to $10.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Qumu Corporation's is 1.5476. This would suggest that Qumu Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Qumu Corporation provides tools to create, manage, secure, distribute, and measure live and on-demand video content for the enterprises. It offers software on a license, cloud-hosted software as a service, or term software license basis; and sells third-party hardware appliances, as well as provides maintenance and support, and professional and other services. The company's platform provides video capture services; video content management services, such as creation and editing, analytics, automated workflows, security and access control, and speech search; and extensions and add-ons. It serves the banking, finance and insurance, manufacturing, services and consulting, telecom and technology, and biotech and health care markets, as well as government customers through direct sales and channel partners in North America, Europe, and Asia. The company was formerly known as Rimage Corporation and changed its name to Qumu Corporation in September 2013. Qumu Corporation was founded in 1978 and is headquartered in Minneapolis, Minnesota. .
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.